The global animal pharmaceuticals market is expected to
grow at a CAGR of 7.7% forecast to 2022.
Request for a sample
of this research report: https://www.psmarketresearch.com/market-analysis/animal-pharmaceuticals-market/report-sample
The growth of the
global market is largely driven by increasing consumption of meat and milk, and
increasing zoonotic and food borne diseases. Due to growing health concern of
related animals and their increasing number, the healthcare expenses in farms
are surging globally.
Animal farms are
increasing globally, due to growing demand for protein rich foods, such as
milk, eggs and meat. Increasing trend of pet adoption is another key factor
driving the growth of the animal pharmaceuticals market.
The declining
research and development productivity and growth of generic and OTC drugs for
animal care are the key trend witnessed in the market.
The ectoparasiticides
generated largest revenue in the global animal pharmaceuticals market. High
prevalence of animals affected with ectoparasites is the key factor driving the
growth of the ectoparasiticides market. The bronchodilators market would
witness fastest growth during the forecast period.
North America
accounted for the largest share in the global market, owing to the large
consumption of meat and milk products. The high level of urbanization leading
to high standard of living is the key reason for large consumption of meat and
milk products in North America. The U.S. contributed largest revenue to the
North American as well as global animal pharmaceuticals market.
Increasing awareness
regarding the livestock related diseases is the key reason behind the higher
growth of the animal pharmaceuticals market for production animals.
Make Enquiry before
buying the report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=animal-pharmaceuticals-market
Some
of the major players operating in the global market include Merck & Co.
Inc., Vetoquinol S.A., Zoetis Inc., Virbac SA, Boehringer Ingelheim GmbH ,
Perrigo Company plc, Eli Lilly and Company, Sanofi and Bayer AG.
Comments
Post a Comment